Quantum-Si (NASDAQ:QSI) Coverage Initiated by Analysts at Alliance Global Partners

Alliance Global Partners assumed coverage on shares of Quantum-Si (NASDAQ:QSI) in a research note issued to investors on Friday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $3.75 target price on the stock.

Several other equities analysts also recently commented on the company. HC Wainwright reiterated a “buy” rating and issued a $5.50 target price on shares of Quantum-Si in a research report on Tuesday, January 14th. Canaccord Genuity Group decreased their price target on shares of Quantum-Si from $1.50 to $1.00 and set a “hold” rating for the company in a research report on Wednesday, November 13th.

Quantum-Si Price Performance

QSI stock opened at $2.04 on Friday. The stock has a market cap of $291.13 million, a price-to-earnings ratio of -3.19 and a beta of 2.70. The company has a 50 day simple moving average of $2.15 and a 200 day simple moving average of $1.35. Quantum-Si has a 1 year low of $0.61 and a 1 year high of $5.77.

Insider Buying and Selling

In other Quantum-Si news, Director Jonathan M. Rothberg sold 3,506,267 shares of the stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $3.34, for a total transaction of $11,710,931.78. Following the completion of the sale, the director now directly owns 1,250,000 shares in the company, valued at approximately $4,175,000. This trade represents a 73.72 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. 30.04% of the stock is owned by insiders.

Institutional Investors Weigh In On Quantum-Si

Several large investors have recently added to or reduced their stakes in the business. Geode Capital Management LLC grew its position in shares of Quantum-Si by 6.7% during the 3rd quarter. Geode Capital Management LLC now owns 2,316,921 shares of the company’s stock worth $2,044,000 after buying an additional 145,091 shares during the period. Charles Schwab Investment Management Inc. raised its holdings in shares of Quantum-Si by 32.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 308,021 shares of the company’s stock valued at $832,000 after purchasing an additional 75,661 shares during the period. Bank of New York Mellon Corp boosted its position in shares of Quantum-Si by 21.3% during the 4th quarter. Bank of New York Mellon Corp now owns 269,807 shares of the company’s stock worth $728,000 after purchasing an additional 47,400 shares in the last quarter. Barclays PLC grew its stake in shares of Quantum-Si by 210.5% in the 3rd quarter. Barclays PLC now owns 196,826 shares of the company’s stock valued at $173,000 after buying an additional 133,438 shares during the period. Finally, Rhumbline Advisers increased its position in Quantum-Si by 3.7% in the 4th quarter. Rhumbline Advisers now owns 148,946 shares of the company’s stock valued at $402,000 after buying an additional 5,298 shares in the last quarter. Institutional investors and hedge funds own 39.90% of the company’s stock.

Quantum-Si Company Profile

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.